Ingredion (INGR) Earnings Date & Reports

Key Takeaways

• Ingredion reported third-quarter 2026 net sales of $1.79 billion, down 1% year over year, though up 2% when excluding its divested Pakistan business.
• Adjusted earnings per share (EPS, a measure of profit divided by shares outstanding) came in at $2.28, below the $2.65 consensus estimate and down from $2.75 a year earlier.
• Adjusted operating income fell 19% to $206 million, pressured by higher manufacturing costs at the Argo facility, record tapioca prices, and a stronger Mexican peso.
• Management lowered its full-year 2026 adjusted EPS guidance to a range of $9.25 to $9.70, down from its prior $10.30 to $10.90 outlook.
• Texture & Healthful Solutions delivered its 10th consecutive quarter of sales volume growth, while the U.S./Canada segment remained under pressure.
• Ingredion raised its quarterly dividend to $0.83 per share, marking its 12th straight year of dividend increases.
• For additional context, explore Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated INGR pages.
• Investors seeking automated market ideas can also explore Tickeron's Trending AI Robots.

Earnings Context and Why It Matters

Ingredion's quarterly results offer a window into global food-ingredient demand and the cost pressures facing food manufacturers. As a leading producer of starches, sweeteners, and specialty ingredients, the company's performance reflects broader trends in consumer spending, agricultural input prices, and currency markets. This report carries added weight because it follows a period of operational disruption at its Argo facility in the U.S., giving investors a clearer read on how quickly that recovery is translating into profit. With the pending Tate & Lyle acquisition in the background, the quarter also signals how management is steering the business through higher costs while positioning for long-term growth.

Reported Results

Ingredion reported third-quarter 2026 net sales of $1.79 billion, a 1% decline from $1.82 billion in the prior-year period. Excluding the divested Pakistan business, net sales rose 2%. Reported diluted EPS from continuing operations was $2.23, down from $2.61 a year earlier, while net income declined to $142 million from $171 million.

On an adjusted basis, which excludes one-time items such as restructuring charges, impairment costs, and acquisition-related expenses, diluted EPS was $2.28, down from $2.75 a year ago and below the $2.65 consensus estimate. Adjusted operating income fell 19% to $206 million.

Segment results were mixed. Texture & Healthful Solutions net sales rose 1%, with volumes up 2% for a 10th consecutive quarter of growth, but operating income fell 10% to $95 million on higher tapioca and manufacturing costs. Food & Industrial Ingredients Latin America (LATAM) grew net sales 7%, yet operating income slipped 6% to $109 million on currency headwinds and an earthquake in Colombia. Food & Industrial Ingredients U.S./Canada saw operating income drop 36% to $52 million, largely reflecting elevated costs at the Argo facility and softer volumes.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market more efficiently. It scans thousands of stocks and ETFs using customizable criteria such as industry, market capitalization, technical indicators, price patterns, and performance metrics, while also surfacing AI-driven signals related to trends and volatility. The screener can help users identify trade ideas, trending stocks, breakout candidates, and emerging market opportunities far faster than manual research. Investors following companies like Ingredion may find it a useful way to monitor sector momentum and uncover related opportunities.

Market Reaction and Investor Sentiment

The third-quarter results fell short of both Wall Street estimates and management's own expectations, with the company citing slower-than-expected profit recovery at Argo and a more cautious consumer-demand outlook. The revenue and EPS misses, combined with a downward revision to full-year guidance, underscore the near-term profit pressure facing the business. Heading into the report, investors had been focused on whether Argo's operational stabilization would begin to flow through to earnings; the quarter showed that recovery remains a work in progress. The stock's reaction to results will likely hinge on how investors weigh those cost headwinds against continued volume growth in higher-value segments and the strategic progress toward the Tate & Lyle acquisition.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be watching several themes that could shape Ingredion's performance over the coming quarters.

The first is the Argo recovery. Production has now stabilized for two consecutive quarters and key inventories have largely been rebuilt, but higher maintenance spending and input costs have not yet translated into improved profitability. Management's ability to normalize operational spending and rebuild customer volumes will be central to restoring U.S./Canada margins.

Input-cost inflation is another key variable. Record-high tapioca prices, driven by weather-related crop shortages in Thailand, and elevated diesel and logistics costs are pressuring margins, particularly in Texture & Healthful Solutions. The company is pursuing targeted pricing and productivity actions, though there is a lag before these offset rising costs.

Finally, the pending Tate & Lyle acquisition remains a significant strategic catalyst. The deal is expected to add roughly $2.7 billion in revenue and deliver substantial cost synergies over time, but integration and financing considerations will be closely monitored. Currency movements in Latin America, particularly the Mexican peso, and the trajectory of consumer demand in the U.S. and Canada round out the list of factors worth watching.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations